Brought to you by 
Quintiles buys HMR's development operations for $93mm
13 Jul 1999
Executive Summary
CRO Quintiles Transnational has acquired the assets of Hoechst Marion's Kansas City-based Drug Innovation and Approval operations and to open up a CRO there in exchange for $93mm in cash.
Deal Industry
- Contract Research, Toxicology Testing-CRO
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Quintiles buys HMR's development operations for $93mm
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice